PetMed Express Faces Listing Rule Issues

Ticker: PETS · Form: 8-K · Filed: 2025-07-03T00:00:00.000Z

Sentiment: neutral

Topics: listing-rule, delisting-notice, financials

Related Tickers: PETS

TL;DR

PETS might be delisted - check listing rules.

AI Summary

PetMed Express, Inc. filed an 8-K on July 2, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard, and also filed financial statements and exhibits. The company is incorporated in Florida and its principal executive offices are located at 420 South Congress Avenue, Delray Beach, Florida.

Why It Matters

This filing indicates potential issues with PetMed Express's continued listing on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: medium — The filing explicitly mentions a notice of delisting or failure to satisfy a continued listing rule, which poses a direct risk to the company's stock.

Key Numbers

Key Players & Entities

FAQ

What specific listing rule or standard has PetMed Express failed to satisfy?

The filing does not specify the exact rule or standard that PetMed Express has failed to satisfy, only that a notice has been issued.

What is the date of the earliest event reported in this 8-K?

The earliest event reported is July 2, 2025.

What are the principal executive offices of PetMed Express, Inc.?

The principal executive offices are located at 420 South Congress Avenue, Delray Beach, Florida 33445.

What is the company's fiscal year end?

The company's fiscal year ends on March 31.

What is the SIC code for PetMed Express, Inc.?

The Standard Industrial Classification (SIC) code is 5912, which corresponds to Retail-Drug Stores and Proprietary Stores.

From the Filing

0001040130-25-000040.txt : 20250703 0001040130-25-000040.hdr.sgml : 20250703 20250703083616 ACCESSION NUMBER: 0001040130-25-000040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250702 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250703 DATE AS OF CHANGE: 20250703 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 251103839 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20250702.htm 8-K pets-20250702 0001040130 FALSE 0001040130 2025-07-02 2025-07-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  July 2, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Global Select Market Preferred Stock Purchase Rights N/A NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, PetMed Express, Inc. (the “Company”) determined that it was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the “Form 10-K”) by the prescribed due date because the Company is continuing to compile, review, and analyze the information necessary to complete its financial statements and related disclosures to be included in the Form 10-K, as more fully described in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on J

View on Read The Filing